
é žåã°ã©ãã§ã³ãã€ããã²ã«ïŒãããã现èã«åæmRNAãæ³šå ¥ãã
é žåã°ã©ãã§ã³ãã€ããã²ã«ïŒãã¹ãŠã®çްèã«åæmRNAãæ³šå ¥ããã
2021幎8æ3æ¥
å
èšäºã¯ãã¡ãã
ãªãŒã»ãªãŒã¹ãã£ã³è
DARPAã®çºæã§ãããã€ããã²ã«ã¯ã人é¡ãç¥ãéãæå°ã§æåŒ·ãã€æé«ã®é»æ°äŒå°äœã§ããé žåã°ã©ãã§ã³ããäœããããœããã³ã³ã¿ã¯ãã¬ã³ãºã«äŒŒããããã§ãããé žåã°ã©ãã§ã³ãã€ããã²ã«ã¯ãã¹ããŒãããã€ã¹ãã¯ã©ãŠããAIãšæ¥ç¶ããããã®å°é»æ§ãæã£ãŠããŸãã1ååãæž¬å®ããé žåã°ã©ãã§ã³ã¯ããã€ããã²ã«ã®äž»èŠãªèŠçŽ ã§ããCOCID-19泚å°ã®åçšéã¯ãé žåã°ã©ãã§ã³ãããã²ã«ã®äžã«å«ãŸããäœå ãã®èªå·±è€è£œããããããå«ã¿ãåè§£ãšåçµã¿ç«ãŠã®èœåãæã£ãŠããã
ã«ã·ãã§ã«ã®ãšãªãŒãã¯ããããããã«äººéãšåæDNAãèåãããAIãšé£åã§ããéãšç²åã®ãã€ããªãããäœãããšã§ã人éã®DNAãäœç³»çã«å€ããããšããŠãããé žåã°ã©ãã§ã³ã®ãã€ããã²ã«ã«å«ãŸãããããããã¯ãç¡é²åãªçްèãåæãããã®äžã«äŸµå ¥ããããšãã§ããŸãã ãã®ããã»ã¹ãäœå åãšç¹°ãè¿ãããäœå ã®ããããèåšã«å«ãŸããå现èããããããã«æç²ãããããããŠãããæç¹ããã人éã¯èãšéå±ã®ãã€ããªããã«å€èº«ãããÂ
é žåã°ã©ãã§ã³ãã€ããã²ã«ã¯ãå·ãç¬æã«æ²»ãèœåãæã£ãŠããããããããé»ç€ºé²13ç« 3ç¯ãç£ã®é ã®äžã€ã¯èŽåœå·ãè² ã£ãŠããããã«èŠãããããã®èŽåœå·ã¯çããããã®åè§Šãã ãããå šäžçã¯é©ãã«æºã¡ãç£ã«åŸã£ãã"Â
人éãããã€ããªãããžã®ç§»è¡ã«ã¯ããããããã矀ãããªããŠè³ã«ç§»åããæçµçã«ããããééã«äœã¿çãããšãå«ãŸããããããããã¯äœå
ããæ°Žåãæ¡åãããããæé·ã®ããã®è¬å€ãšããŠå©çšããããããŠã人éãæ§æããæ¬æ¥ã®çç©åŠçãªéšåãæ¯ãå§ããæ»ãã§ããã 人éã®æ»ãããã€ããªããã®èªçãå§ãŸãã
SPIONSã¯ãSuperparamagnetic Iron Oxide Nanoparticlesã®é æåããšã£ããã®ã§ã现è䟵å
¥ã®ããã»ã¹ã容æã«ããŸããSPIONSã¯Magnetofectionã«ããç£æ°ã垯ã³ãããšãã§ããåæã¹ãã€ã¯ã¿ã³ãã¯è³ªã现èå
ãžéã¶ããšãã§ããŸãã
ãã°ãããã§ã¯ã·ã§ã³ã¯ãç£æ§ç²åã«çµåããéºäŒåãã¯ã¿ãŒã«åãç£åãå©çšãããã¯ã¿ãŒãæšç现èãžãå Žåã«ãã£ãŠã¯çްèå ãžåŒã蟌ãããšãã§ããŸãããã®æ¹æ³ã§ã¯ãé©çšããããã¯ã¿ãŒã®å šéãæ°å以å ã«çްèã«éäžããã现èã®100ïŒ ãããªãã®éã®ãã¯ã¿ãŒãšæ¥è§Šããããã«ããã"
COVID-19ãªãã¬ãŒãã£ã³ã°ã·ã¹ãã ã€ã³ãžã§ã¯ã·ã§ã³ã«é©çšãããšãç£æ°ãç®ã«èŠããªãåãšãªãã现èãå²ã£ãŠãã¯ã¿ãŒã§ããã¹ãã€ã¯ã¿ã³ãã¯è³ªãéã蟌ãããšãã§ããããã«ãªããŸããÂ ç£æ°ããªããã°ãã¹ãã€ã¯ã¿ã³ãã¯è³ªã¯äœå ã®ãã¹ãŠã®çްèã«æµžéããããšãã§ããŸãããç£æ°ã¯ãã¹ãã€ã¯ã¿ã³ãã¯è³ªã现èå ã«éã蟌ãããã®ãšã³ãžã³ã ãšèããŠãã ããã
ç ç©¶è ã®ãžã ã»ã¹ããŒã³ã«ããã°ããããããã¯äœããäœãããã«è¡æ¶²äžã®ãã¢ã°ãããªã³ïŒé žåéã®äžçš®ïŒãæ¡åããŠããããã ãšãããé žåã°ã©ãã§ã³ç£æ§ãããã²ã«ã¯ãé žåéããŒã¹ã®ç²åã§æ§æãããŠããã®ã§ãããã¯ããªãå¯èœæ§ãé«ãããžã ã¯èªåã®ãµã€ãã«ããæžããŠããã
ãç§ã¯ãç£æ°ã垯ã³ãã¯ã¯ãã³ã«å ¥ã£ãŠãããã®ã¯ãããçš®ã®èªå·±è€è£œãããããã¯ã ãšæããŸãïŒãããã¯æ³šå ¥ãããŠããŸããïŒãVaxã«äœ¿ãããéã¯IDãããã«ã¯å°ããããããIDãããã¯ãã«ãµã€ãºã§ãç£ç³ãåŒãã€ããã«ã¯ååã§ã¯ãªãã§ãããã
ããããããããã«äœå ã®ç£æ°æ§é ãäœãããã®ã§ããã°ããã®ãããããã¯ãäœå ã§å©çšã§ãããã®ã§ããã°äœã§ã䜿ããããã«ããªããã°ãªããŸãããäœå ã§å®¹æã«å©çšã§ããç£æ§éå±ã¯ãè¡æ¶²äžã®ãã¢ã°ããã³ã ãã§ããããã¯ãããžãŒã»ããã€ã¹ã¯ããã§äœããäœãããã®éãæã«å ¥ããããšãã§ããŸãã1CC以äžã®æ³šå°ã§ãããã»ã©ç£æ°ã垯ã³ããšã¯æããŸãããã€ãŸããç£ç³ãç®èãéããŠãã£ã€ãã®ã§ããã°ãç®èã®äžã«ãããã®ã¯ãã¹ãŠèªåã®äœããåºããã®ã§ãªããã°ãªããªãã
æåã¯ã泚å°ã®ãããããããªãããããªãžã ç£ç³ã§ãªããšå¹æã¯ãªãã ãããšæããŸãããããããæ®éã®ã»ã©ããã¯ç£ç³ãå·èµåº«ã®ç£ç³ã§ã广ããããããã4ã€ã³ãåæ¹ã®é¢ç©ã«å匷ãå¹ãããšãå€ãã®ã§ããããã¯ããªã³ãžå¹æã§ã¯ãããŸãããããã¯äœãé倧ãªããšãèµ·ãã£ãŠããã®ã§ããããã¯ãäœãéå±ãç£å Žãçºãããã®ãäœãããã«æç€ºãããŠããããšã§ãã
è¡æ ã¯ã泚å°ããããããã®æãæŸåºããè¡æ¶²ãæ»æããŠãã¢ã°ããã³ã奪ããæ³šå°éšäœã§äœããäœãããã«èµ·ãã£ãŠãããšãããã©ãã§ãããïŒããã¯Â "ããã "ã§ã¯ãªãã ããã
ãªãŒã»ãªãŒã¹ãã³ã¯ã"ã¢ãŒãã³ã°ã¹ã¿ãŒç©èªÂ "ã®èè ã§ãããÂ
©2017 by NutriTruth. ãã©ãŠã
åèåç»
1Â Â å
ãã¡ã€ã¶ãŒç ç©¶å¡ã®è©±ã
äœå
ã«æ°žä¹
çã«çãŸãèç©ãããé
žåã°ã©ãã§ã³ã¯é»æ°èªå°äœã§ããã"ã¯ã¯ãã³æåãšããŠæå
¥ãããããããŒã"ãš5Gãšãçµã³ã€ãããå°æ¥ã®ã€ã³ã¿ãŒããããšèº«äœã®çµåïŒ"IoB"ã®çºãçŸåšã¯äººäœã䜿ã£ãŠæè¡çå®éšã®æ®µéãïŒ
2  ãã«ããã€ããã²ã«ãšéåãããã®é¢ä¿ãã¯ã¯ãã³æåãŒã»ã¬ã¹ãã®è§£èª¬
åèèšäº
1  DARPA COVIDã¯ã¯ãã³ã®ãã€ããã²ã«ã¯ãçµæ¶ã5Gã¿ã¯ãŒããã®ä¿¡å·ãåä¿¡ããããã¢ã³ãããäœæããããšãã§ããŸãã
2  (Campra, P. 2021ïŒãæ®åœ±ããé¡åŸ®é¡ç»åã¯ãã¯ã¯ãã³ç¶ã®å
容ç©ãæè³ªãè§£æããããã®è²Žéãªæ
å ±ãæäŸãç¶ããŠããŸããä»åãéèŠãªèšŒæ ãèŠã€ãããååã®DNA-ãªãªã¬ãã®èªå·±çµç¹åã®èšŒæ ãšåæ§ã«ãComirnatyâ¢Â Pfizerã¯ã¯ãã³ãDNAçµæ¶ã®èªå·±çµç¹åæè¡ãåããŠããããšã確èªãããããšã«ãªãã
3  ãã°ããã¹ããªãªãŠã ãŒã¯ã¯ãã³å ã§çºèŠããããã¯ããªã¢ã¯ãéãéããç¹æ®ãªæ¶²èãäœãªããæéããããŠãã°ãã¿ã€ãã®ãããªãã§ãªãã°ãã¿ã€ãéé žåç©ã®åçµæ¶ã圢æããèœåãããã